ProQR Therapeutics N.V. to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

ProQR Therapeutics announced upcoming presentations on clinical and preclinical progress for AX-0810, AX-0811, and its broader Axiomer RNA editing platform. Presentations are planned at TIDES Europe, The Liver Meeting 2026, and Nature Conferences RNA at the Bench and Bedside V; the announcement provides no trial results or numerical data.